Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Moringa Oleifera on Bone Density

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03026660
Recruitment Status : Completed
First Posted : January 20, 2017
Last Update Posted : January 20, 2017
Sponsor:
Collaborator:
North Carolina Agriculture & Technical State University
Information provided by (Responsible Party):
Edward Merritt, Appalachian State University

Brief Summary:
The purpose of this study is to determine the effects of Moringa Oleifera on the structure and function of bone in post-menopausal women ingesting 1000 mg of Moringa Oleifera daily for 12 weeks.

Condition or disease Intervention/treatment Phase
Osteoporosis, Osteopenia Postmenopausal Osteoporosis Dietary Supplement: Moringa Oleifera Dietary Supplement: Cabbage Placebo Not Applicable

  Show Detailed Description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 20 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Basic Science
Official Title: Effect of Moringa Oleifera on Bone Density in Post-Menopausal Women
Study Start Date : July 2015
Actual Primary Completion Date : February 2016
Actual Study Completion Date : May 2016

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Bone Density

Arm Intervention/treatment
Experimental: Moringa treatment
Moringa Oleifera was distributed in two 500mg capsules of dried and powdered Moringa Oleifera leaves. Two capsules were taken daily.
Dietary Supplement: Moringa Oleifera
Placebo Comparator: Placebo
The placebo consisted of dried and powdered cabbage in two 500mg capsules. Two capsules were taken daily.
Dietary Supplement: Cabbage Placebo



Primary Outcome Measures :
  1. Bone Density [ Time Frame: 12 weeks after start of intervention ]
    Measured by Dual Energy X-Ray Absorptiometry



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   60 Years to 70 Years   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Gender Based Eligibility:   Yes
Gender Eligibility Description:   Females only
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Between 60 -70 years old
  • Female

Exclusion Criteria:

  • Fracture in non-dominant forearm/wrist or lower leg.
  • Currently taking blood thinners
  • Currently taking estrogen supplements
  • Have had a hysterectomy

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03026660


Locations
Layout table for location information
United States, North Carolina
Appalachian State University
Boone, North Carolina, United States, 28608
Sponsors and Collaborators
Appalachian State University
North Carolina Agriculture & Technical State University
Investigators
Layout table for investigator information
Principal Investigator: Edward K Merritt, PhD Appalachian State University

Publications:

Layout table for additonal information
Responsible Party: Edward Merritt, Assistant professor, Appalachian State University
ClinicalTrials.gov Identifier: NCT03026660     History of Changes
Other Study ID Numbers: 15-0257
First Posted: January 20, 2017    Key Record Dates
Last Update Posted: January 20, 2017
Last Verified: January 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Edward Merritt, Appalachian State University:
Moringa Oleifera
Additional relevant MeSH terms:
Layout table for MeSH terms
Osteoporosis
Bone Diseases, Metabolic
Osteoporosis, Postmenopausal
Bone Diseases
Musculoskeletal Diseases
Metabolic Diseases